The occasional complaints of readers asserting bias in this newspaper’s selection and publication of opinion pieces and letters are unwarranted. To do so, some engage in counting the number of pro and ...

Abbott (NYSE: ABT) today announced late-breaking data from the AVEIR™ Conduction System Pacing (CSP) acute clinical feasibility study, which demonstrated the safety and performance of the ...